Primal Therapies
Boise, US · Founded 2012 · Delaware corporation
Founders & leadership
MO
Michael O'DonnellExecutive
ES
Emily SteinNamed on SEC filing
Board
TF
Terry FademAppointment effective upon this financing.
DE
David EigenAppointment effective upon this financing.
Reported raises · per SEC filings
Form D private placements$677K disclosed across 1 round · 2016
▶$677KraisedOct 2016 · 8 investors · BiotechnologyRule 506(b)
▶$677KraisedOct 2016 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Terry FademDirector
- David EigenDirector
- Emily SteinExecutive Officer, Director
- Michael O'DonnellExecutive Officer
- Offering amount
- $1.1M
- Amount sold
- $677K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $206.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has Primal Therapies raised?
- Primal Therapies has disclosed $677K raised across 1 round.
- Where is Primal Therapies headquartered?
- Primal Therapies is headquartered in Boise, US.